Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
IRadimed Corporation

IRadimed Corporation (IRMD) Stock Overview

Explore IRadimed Corporation’s financial performance, market position, analyst ratings, and future outlook.

IRMD●NASDAQ
HealthcareMedical - Devices
$87.16
$0.24(0.27%)
U.S. Market opens in 3h 6m

IRadimed Corporation (IRMD)

Meyka AI Score

Z

Key Financials

Market Cap1.1B
P/E Ratio48.21
EPS (TTM)$1.99
ROE0.23%
Fundamental Analysis

AI Price Forecasts

1 Month$94.94
3 Months$111.95
1 Year Target$119.19

IRMD Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of IRadimed Corporation (NASDAQ: IRMD) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, IRadimed Corporation's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IRMD on the NASDAQ shows an RSI of 34.47, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $119.19 for the NASDAQ listing.

Key metrics behind IRadimed Corporation's NASDAQ-traded stock include a P/E ratio of 48.21 and a market capitalization of 1.1B. Combined with our AI analysis, these give both institutional and retail investors a clear view of IRMD on the NASDAQ.

Price Performance (NASDAQ: IRMD)

1-Day Change
-0.27%
5-Day Change
-4.64%
1-Month Change
-10.78%
3-Month Change
2.22%
6-Month Change
-12.67%
Year-to-Date (YTD) Change
-10.40%
1-Year Change
22.76%
3-Year Change
79.08%
5-Year Change
156.88%
All-Time (Max) Change
780.40%

Contact Information

https://www.iradimed.com
407 677 8022
1025 Willa Springs Drive, Orlando, FL, 32826

Company Facts

1,660 Employees
IPO DateJul 16, 2014
CountryUS
Actively Trading

Frequently Asked Questions